Orgovyx® (relugolix) 120 mg tablets for advanced prostate cancer

What Orgovyx® Is and How It Works

Orgovyx® (relugolix) is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist used to treat adults with advanced prostate cancer. It lowers testosterone quickly without a hormone surge. The usual maintenance is one 120 mg tablet each day after a loading dose. Many people compare Orgovyx cost and orgovyx price across pharmacies because this therapy can be long term.

YouDrugstore is a licensed Canadian pharmacy based in Manitoba that meets Canadian pharmacy standards. Orders are reviewed by licensed pharmacists before dispensing, and you can shop brand and generic medicines at Canadian prices. Ordering is online, and customer-service chat is available during posted office hours.

To broaden access and pricing, we also work with licensed, vetted international partner pharmacies that supply authentic brand medications at fair, competitive rates and a wide selection.

Drug class: GnRH receptor antagonist. Primary indication: androgen-deprivation therapy for prostate cancer. Route and form: oral tablets. Typical cadence: one 120 mg tablet daily following an initial loading dose.

Relugolix (the active ingredient in this orgovyx medication) blocks pituitary GnRH receptors. This reduces luteinizing hormone and follicle-stimulating hormone, which lowers testicular testosterone. Suppression happens within days and avoids the initial flare seen with GnRH agonists.

Dosage and Usage

Follow your prescriber’s instructions and the orgovyx prescribing information. Typical dosing steps are:

• Day 1: 360 mg loading dose (three Orgovyx 120 mg tablets).
• Thereafter: Orgovyx 120 mg once daily at the same time each day.
• With or without food. Swallow tablets whole; do not crush or split.
• Missed dose: if remembered within 12 hours, take the dose; otherwise skip and resume the next day.
• Interruption: if therapy stops for more than 7 days, reinitiation may require the 360 mg loading dose, then 120 mg daily.
• Drug interactions: avoid combined P-gp and strong CYP3A inducers when possible. If a P-gp inhibitor is unavoidable, separation by at least 6 hours from Orgovyx may be recommended. The care team will advise on any dose changes.
• Monitoring: clinicians often check testosterone and PSA to confirm response.

Storage and travel tips:

• Store at 20–25 °C (68–77 °F); short excursions 15–30 °C are permitted.
• Keep tablets in the original bottle with the desiccant. Close the cap tightly to protect from moisture.
• Keep out of reach of children and pets.
• For trips, pack your Orgovyx 120 mg tablet supply in carry-on baggage with the original label.
• Bring enough tablets for your entire trip, plus a few extra days.
• Keep the bottle dry and away from heat or direct sunlight.

Benefits and Savings

Key clinical benefits include rapid testosterone suppression, no initial testosterone flare, and an oral once-daily dosing schedule. Many patients value avoiding injections and clinic visits. Orgovyx fda approval was granted for advanced prostate cancer based on the HERO study, which showed quick and sustained testosterone control.

Convenience matters for long-term therapy. Tablets make storage and travel simpler, and testosterone tends to recover faster after treatment is stopped than with some depot injections. These features support long-term treatment plans shaped by the oncology team.

You can expect significant price differences between countries. Ordering through a licensed Canadian pharmacy can offer 60–80% savings versus typical U.S. prices. This helps lower the cost of orgovyx over months of treatment.

Side Effects and Safety

Most people tolerate therapy, but side effects can occur. Read the orgovyx prescribing information and speak with the care team about risks and monitoring.

• Common side effects: hot flashes, fatigue, musculoskeletal pain, diarrhea, constipation, headache, increased glucose, weight gain, decreased libido, erectile dysfunction.
• Other reported effects: liver enzyme elevations, anemia, changes in lipids, injection-site issues are not applicable (tablets).
• Serious side effects: cardiovascular events (such as myocardial infarction or stroke), QT prolongation or arrhythmias, severe hepatic laboratory abnormalities, fractures or bone density loss over time, allergic reactions.
• Drug interactions: P-gp inhibitors/inducers and strong CYP3A modulators may change exposure. The team may adjust dosing or avoid certain combinations.
• Use caution with other QT-prolonging agents and in patients with electrolyte abnormalities or congenital long QT.

Report new or worsening symptoms promptly to the prescriber. Never stop or change the dose without medical guidance.

Onset Time

Testosterone suppression begins quickly. Many patients show reductions within days. In clinical data, castrate levels were achieved by day 4 in a large portion of participants and maintained by day 15 for most. Symptom changes, such as improvements in urinary or bone pain symptoms, may take longer and vary by individual and disease stage.

Compare With Alternatives

Several therapies reduce testosterone or block androgen signaling. GnRH agonists such as leuprolide depot (Lupron Depot®) and goserelin cause an initial testosterone surge before suppression. GnRH antagonists avoid that surge. Degarelix (Firmagon®) is an injectable antagonist; Orgovyx® provides an oral option in the same class.

Androgen receptor–targeted agents can be used with androgen-deprivation therapy in some settings. Examples include abiraterone acetate and enzalutamide. When oral intensification is appropriate, abiraterone (see Zytiga®) may be added with prednisone under oncology guidance.

Another option is bilateral orchiectomy, which offers permanent testosterone suppression but is not reversible. Treatment selection depends on disease stage, comorbidities, drug interactions, access, and patient preference.

Combination Therapy

Orgovyx® may be used alone for androgen deprivation or with other modalities. In localized high-risk disease, androgen-deprivation therapy is often combined with radiation. In metastatic hormone-sensitive disease, clinicians may add agents such as abiraterone/prednisone, enzalutamide, or apalutamide. In later lines, chemotherapy or radiopharmaceuticals may be used. Decisions are individualized to goals, tolerability, and clinical guidelines.

Patient Suitability and Cost-Saving Tips

This orgovyx drug is intended for adult men with advanced prostate cancer who need medical castration. Suitability considerations include the need for quick testosterone suppression, preference for a daily tablet over injections, and potential interactions with P-gp or CYP3A modulators. Cardiac history, including arrhythmias or long QT, should be reviewed. Liver function and blood glucose may be monitored during care.

You can lower per-month costs by choosing multi-month supplies when appropriate. Reorder reminders can help you avoid gaps in therapy. Check current bulk promotions and any available orgovyx coupon offers to see what fits your budget. You can also explore our Cancer category for related therapies and read our article Cancer Drugs List Common Medications And Their Uses for background on common oncology medications.

YouDrugstore offers caring support from order to delivery. Pharmacists review prescriptions before dispensing and can address medication questions. Customer-service chat is available during posted office hours.

Authoritative Sources

For full details, see the manufacturer and regulator resources:

• Orgovyx manufacturer product page (Myovant/Pfizer)
• Health Canada Drug Product Database for relugolix
• FDA Prescribing Information for Orgovyx

Ready when you are. Order from YouDrugstore for pharmacy-checked therapy, caring service, and prompt, express, cold-chain shipping to the U.S. when temperature control is required.

Disclaimer: This content is for general information only and does not replace medical advice. Always consult your healthcare provider for diagnosis, treatment decisions, and personalized dosing.